Patents by Inventor Songyuan Li

Songyuan Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240182890
    Abstract: The present disclosure provides a polynucleotide comprising an RNA guide sequence, a Cas-binding region, and a DNA template sequence. The disclosure also provides compositions comprising a Cas nuclease or a Cas nickase and one or more polynucleotides comprising a guide sequence, a Cas binding region, and a DNA template sequence. The disclosure further provides a fusion protein comprising a Cas nuclease or a Cas nickase and a DNA polymerase recruitment moiety. Also provided are methods for providing a targeted insertion in a target DNA of a cell.
    Type: Application
    Filed: April 6, 2022
    Publication date: June 6, 2024
    Inventors: SONGYUAN LI, MARCELLO MARESCA, SASA SVIKOVIC
  • Patent number: 11920083
    Abstract: This invention relates to a surfactant composition, production and use thereof in tertiary oil recovery. The present surfactant composition comprises a cationic surfactant and an anionic-nonionic surfactant, and exhibits significantly improved interfacial activity and stability as compared with the prior art. With the present surfactant composition, a flooding fluid composition for tertiary oil recovery with improved oil displacement efficiency and oil washing capability as compared with the prior art could be produced.
    Type: Grant
    Filed: June 11, 2020
    Date of Patent: March 5, 2024
    Assignees: CHINA PETROLEUM & CHEMICAL CORPORATION, SHANGHAI RESEARCH INSTITUTE OF PETROCHEMICAL TECHNOLOGY, SINOPEC
    Inventors: Yingcheng Li, Songyuan Gu, Weidong Zhang, Xinning Bao, Zhiqin Shen, Hengzhi Tang, Xiaodong Zhai
  • Publication number: 20220162648
    Abstract: The present disclosure provides methods of introducing site-specific mutations in a target cell and methods of determining efficacy of enzymes capable of introducing site-specific mutations. The present disclosure also provides methods of providing a bi-allelic sequence integration, methods of integrating of a sequence of interest into a locus in a genome of a cell, and methods of introducing a stable episomal vector in a cell. The present disclosure further provides methods of generating a human cell that is resistant to diphtheria toxin.
    Type: Application
    Filed: April 9, 2020
    Publication date: May 26, 2022
    Inventors: Marcello MARESCA, Songyuan LI
  • Publication number: 20190367930
    Abstract: The present invention generally relates to industrial microbiology, and specifically to the production of biochemical compounds, such as L-serine, L-tyrosine, mevalonate and their derivatives, and recombinant polypeptides using genetically modified microorganisms. More particularly, the present invention pertains to the decoupling of cell growth from production of biochemical compounds, such as L-serine, L-tyrosine, mevalonate and their derivatives, in a microorganism by down regulating the nucleotide biosynthesis in said microorganism.
    Type: Application
    Filed: July 28, 2017
    Publication date: December 5, 2019
    Inventors: Songyuan Li, Christian Bille Jendresen, Lasse Ebdrup Pedersen, Jenny Landberg, Kristoffer Bach Falkenberg, Hemanshu Mundhada, Alex Toftgaard Nielsen